The US Food and Drug Administration (FDA) has issued a new guideline on the use of dental amalgam. The FDA recommends that mercury-containg fillings should no longer be used for patients with neurological diseases such as multiple sclerosis, Alzheimer’s and Parkinson’s, as well as patients